Results 101 to 110 of about 6,060,916 (264)

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Outstanding Business Reference Sources 2015

, 2016
A selection of business reference sources for ...
BRASS Business Reference Sources Committee
core  

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Outstanding Business Reference Sources 2013

, 2014
A selection of business reference sources for ...
BRASS Business Reference Sources Committee
core  

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Outstanding Business Reference Sources 2014

, 2015
A selection of business reference sources for ...
BRASS Business Reference Sources Committee
core  

Demographic and laboratory results of healthy donors in reference interval study.

, 2019
Demographic and laboratory results of healthy donors in reference interval study.
Jasper A. Remijn (6331226), Hilde Kelchtermans (12561), Philip G. de Groot (167182), Lisa N. van der Vorm (6331220), Dana Huskens (211452), Walid Chayouâ (6331223), Bas de Laat (339246), Li Li (14993), Mark Roest (377867)   +8 more
core   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Outstanding Business Reference Sources 2012

, 2013
A selection of business reference sources for ...
BRASS Business Reference Sources Committee
core  

Map of 21 laboratories in China selected to perform reference interval validation.

, 2013
Map of 21 laboratories in China selected to perform reference interval validation.
Runqing Mu (458537), Lanlan Wang (160537), Jie Zhang (64655), Xiaoke Hao (458540), Xianzhang Huang (458541), Wenxiang Chen (458538), Chuanbao Zhang (458543), Wei Guo (86150), Min Zhao (66793), Junhua Zhuang (458545), Hong Shang (248168), Rui Qiao (458542), Yueyun Ma (271018), Hengjian Huang (458544), Baishen Pan (458539)   +14 more
core   +1 more source